Navigation Links
Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
Date:6/2/2008

p>

This press release contains forward-looking statements regarding the potential of NKTR-102 and the company's PEGylation technology platform. These forward-looking statements involve important risks and uncertainties, including but not limited to: (i) preclinical testing and clinical trials for NKTR-102 are long, expensive and uncertain processes, (ii) because the NKTR-102 product development programs are in the early phases of clinical development, the risk of failure is high and can occur at any stage of development, (iii) the company may fail to obtain regulatory approval of NKTR-102, (iv) the timing or success of the commencement or conclusion of NKTR-102 clinical trials is subject to a number of uncertainties including but not limited to clinical design, patient enrollment, regulatory requirements and clinical outcomes, (v) potential competition from existing approved products (branded or generic) or product candidates under development by other companies could negatively impact the commercial potential of NKTR-102 due to such common industry competitive factors as efficacy and safety profiles, pricing, and reimbursement by third party payers, and (vi) the company's patent applications for NKTR-102 may fail to issue; patents that have issued may not be enforceable; or unanticipated intellectual property licenses from third parties may be required in the future. Other important risks and uncertainties are detailed in the company's reports and other filings with the SEC including its Quarterly Report on Form 10-Q filed with the SEC on May 9, 2008. Actual results could differ materially from the forward-looking statements contained in this press release. The company undertakes no obligation to update forward-looking statements, whether as a result of new information, future events, or otherwise. No information regarding or presented at the scientific meetings referred to above (or contained at the Internet links provided) is intended to be incorporated by refe
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 BioSpecifics Technologies Corp. (Nasdaq: ... class collagenase-based products, today announced top-line efficacy and ... of XIAFLEX(TM) for the treatment of Peyronie,s disease. ... inelastic collagen on the shaft of the penis, ... intercourse difficult or impossible in advanced cases. The ...
(Date:12/16/2009)... CORALVILLE, Iowa, Dec. 16 Vivakor, ... a Business Development agreement with Baker Consulting ... affiliate group, Kyouko Group, Inc. out of ... retained by Vivakor to assist with business ... its recently reported acquisition strategy. Specifically, Baker ...
(Date:12/16/2009)... Naurex Inc., a new clinical stage ... CNS disorders based on its novel GFPA NMDA ... a Phase I clinical trial of its lead ... subjects in the study. GLYX-13, a glycine ... the NMDA receptor, is initially being developed as ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4Vivakor Signs Business Development Agreement With Baker Consulting 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3Success of National Fundraising Event Critical to Promising Research for Life Threatening Kidney Disease 56820 1Success of National Fundraising Event Critical to Promising Research for Life Threatening Kidney Disease 56820 2Income Poverty and Health Insurance Coverage in The United States 3A 2008 56818 1Income Poverty and Health Insurance Coverage in The United States 3A 2008 56818 2Income Poverty and Health Insurance Coverage in The United States 3A 2008 56818 3Income Poverty and Health Insurance Coverage in The United States 3A 2008 56818 4Income Poverty and Health Insurance Coverage in The United States 3A 2008 56818 5Income Poverty and Health Insurance Coverage in The United States 3A 2008 56818 6Regions Hospital Selected to Participate in National Cardiac Care Quality Improvement Effort 56815 1Regions Hospital Selected to Participate in National Cardiac Care Quality Improvement Effort 56815 2Regions Hospital Selected to Participate in National Cardiac Care Quality Improvement Effort 56815 3
(Date:12/16/2009)... has never felt so good for "The Biggest Loser" ... means continuing to make smart choices everyday to help ... healthy choice that is an important part of living ... Every glass of milk has nine essential nutrients like ... blood pressure, and calcium and vitamin D for strong ...
(Date:12/16/2009)... Dec. 16 As a result of C3: ... new peer reviewed cancer research program is included in ... ,, This new cancer research program will research cancers, ... breast, prostate, lung and ovarian cancer research programs run ... ,, The $15 million in funding for ...
(Date:12/16/2009)... it plays a role in reducing inflammation in the ... gene variant that plays a role in inflammation seems ... well as adults who smoke. , Researchers also found ... gene had a lower risk of developing chronic obstructive ... by smoking. , "The gene seems to be protective ...
(Date:12/16/2009)... The omega-3 essential fatty acids commonly found ... sensory overload, according to research published by the ... to the information-processing problems found in people with ... disease; and other afflictions of the nervous system. ... Behavioral Neuroscience , provides more evidence that ...
(Date:12/16/2009)... no direct link has been found, , , WEDNESDAY, Dec. ... -- commonly linked to food poisoning and the stomach ... the cause of some urinary tract infections. , Researchers ... chicken from stores and restaurants and in women with ... germs were transmitted directly to the women through the ...
Breaking Medicine News(10 mins):Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:Gene Variant Seems to Guard Against Asthma, COPD 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 3Health News:New study links DHA type of omega-3 to better nervous-system function 2Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3
... Carr, an outspoken adversary of smoking and a former 100-cigarette-a-day ... the age of 73.// ,Allen Carr has written ... to give up the unhealthy habit, had earlier today confirmed ... more than 23 years ago I have been the happiest ...
... Researchers from the U.S. Department of Agriculture have indicated ... as against cold Watermelon. // ,According to ... after they are severed from the parent plant, which ... said that watermelons kept at 70 degrees, contained almost ...
... went wrong could now develop serious illnesses like cancer according ... of the trials at Northwick Park Hospital in north-west London ... Day, a solicitor for several of these men said that ... ,Parexel, a clinical research organization, which arranged the trials, ...
... leaders of Deoband, Meerut and Delhi have issued a joint ... campaign to prevent children from becoming a prey to the ... Deoband in Saharanpur, Jamiat Ulema-e-Hind in New Delhi, city Qazi ... signed the joint appeal asking the people of the community ...
... Channel 7 Indian Television network has raised many questions about ... A cleaning up operation is long overdue to rejuvenate the ... Medical Association in 1949 - I solemnly ... humanity …. I will practice my profession with conscience and ...
... Pennsylvania School Of Medicine suggest that the human retina is ... an Ethernet// connection, which is one of the known local ... of neural systems with artificial ones, as a means ... information. These findings have been presented in the July issue ...
Other Medicine News:Health News:Maimed Conscience and Maimed Beggars (Medical Ethics in India) – Part 2Health News:Maimed Conscience and Maimed Beggars (Medical Ethics in India) – Part 3Health News:Maimed Conscience and Maimed Beggars (Medical Ethics in India) – Part 4Health News:Measuring the Quantity of Information Passed on From the Eye to the Brain 2Health News:Measuring the Quantity of Information Passed on From the Eye to the Brain 3
Orthofix's retrograde nail provides easier insertion of nail by rotational movements....
... design philosophy of the Quad 4™ Intramedullary ... system that could be used for the ... requirements of the system were to minimize ... complete inventory, with one system that could ...
... Fast and easy voice access to information ... SoundAdvice is easy and intuitive, enabling you ... your keyboard. With the VoiceBox Voice Information ... about hundreds of subjects and topics and ...
... Magnetic stimulation is a non-invasive and ... central nervous system. Cadwell Laboratories manufactures two ... High Speed Magnetic Stimulator (HSMS). The Hight ... stimulation rates up to 25 Hz at ...
Medicine Products: